131 |
Reopro Eluting Stents in Acute Coronary Syndrome |
Myung-Ho Jeong |
Jul. 15. 05 |
130 |
ABT 578 Drug-Eluting Stents II: Preclinical Observations and the Clinical Trial Strategy for the Abbott ZoMax Stent |
Alan C. Yeung |
Jul. 15. 05 |
129 |
Update on Jupiter l and ll Clinical Trials with the Sorin Carbostent Tacrocimus Eluting Stent |
Gian Battista Danzi |
Jul. 15. 05 |
128 |
Terumo DES Program -Nobori 1 Clinical Trial |
Hidehiko Honda |
Jul. 15. 05 |
127 |
Update on the Endeavor I-V Trials: The Latest Results |
Ian T. Meredith |
Jul. 15. 05 |
126 |
Drug-Eluting Biodegradable Igaki-Tamai Stent |
|
Jul. 15. 05 |
125 |
ZoMaxx: Abbott's Drug Eluting Stent Program |
John Ormiston |
Jul. 15. 05 |
124 |
Everolimus Drug-Eluting Stents I: Review of Guidant FUTURE I and II, and Status Update of FUTURE III and IV |
Eberhard Grube |
Jul. 15. 05 |
123 |
DES for Complex Patients Subsets |
Alexandre Abizaid |
Jul. 15. 05 |
122 |
DES for Bifurcation Lesion |
Yean Teng Lim |
Jul. 15. 05 |